XML 61 R46.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Restatement of Consolidated Financial Statements - Schedule of the Reconciliation Impact Recorded to the Consolidated Balance Sheet (Details) - USD ($)
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
ASSETS                
Investment in unconsolidated entities $ 9,001,646 $ 8,878,974 $ 503,100   $ 3,901,617      
Option to purchase equity securities in related parties 6,373,402       960,968      
Property and equipment, net 524,656 116,427     2,877,590      
Total assets 22,752,297 18,730,839     13,870,827      
LIABILITIES AND STOCKHOLDERS' DEFICIT                
Accounts payable 345,378 586,687     2,285,894      
Accrued expenses 8,493,358 7,895,653     17,615,507      
Loans payable 7,903,074 4,199,152     663,536      
Litigation financing and other 52,817,938       45,368,948      
Deferred revenue 679,706 700,353     960,968      
Warrant liability 15,792,385       13,602,467      
Total liabilities 108,658,831 94,571,902     102,545,769      
Commitments and contingencies (Note 18)          
STOCKHOLDERS' DEFICIT                
Additional paid-in capital 263,616,186 263,024,673     256,963,264      
Accumulated deficit (296,096,957) (287,879,984)     (301,442,776)      
Total liabilities and stockholders' deficit $ 22,752,297 $ 18,730,839     13,870,827      
As Reported [Member]                
ASSETS                
Investment in unconsolidated entities     4,842,925 $ 4,676,092 4,404,717 $ 4,147,008 $ 3,848,925 $ 3,548,925
Option to purchase equity securities in related parties         0      
Property and equipment, net     2,554,544 2,608,146 2,746,467 306,348 320,107 18,538
Total assets     13,985,687 13,162,380 13,281,836 14,337,383 17,818,610 8,967,281
LIABILITIES AND STOCKHOLDERS' DEFICIT                
Accounts payable     932,902 1,438,698 2,285,892 2,568,554 2,734,296 5,677,097
Accrued expenses     36,919,178 32,809,997 40,481,204 37,715,418 33,978,084 30,827,610
Loans payable     38,708,182 34,204,032 25,011,049 24,354,604 24,174,983 19,483,909
Litigation financing and other         0      
Deferred revenue         0      
Warrant liability         0      
Total liabilities     79,003,168 70,615,864 89,826,594 85,281,657 81,671,905 81,412,863
Commitments and contingencies (Note 18)    
STOCKHOLDERS' DEFICIT                
Additional paid-in capital     271,083,470 270,608,427 265,882,279 264,621,682 264,323,108 249,189,881
Accumulated deficit     (287,354,763) (281,631,073) (298,231,607) (293,459,800) (288,004,571) (283,321,086)
Total liabilities and stockholders' deficit     13,985,687 13,162,380 13,281,836 14,337,383 17,818,610 8,967,281
Litigation Financing Adjustment [Member]                
ASSETS                
Investment in unconsolidated entities         0      
Option to purchase equity securities in related parties         0      
Property and equipment, net         0      
Total assets     0   0      
LIABILITIES AND STOCKHOLDERS' DEFICIT                
Accounts payable         0     0
Accrued expenses     (28,940,418) (25,886,275) (22,865,695) (19,779,018) (16,694,822) (13,789,304)
Loans payable     (23,706,580) (23,493,443) (24,347,513) (24,204,704) (24,025,083) (19,334,009)
Litigation financing and other         45,368,948      
Deferred revenue         0      
Warrant liability         0      
Total liabilities     (3,902,384) (2,322,725) (1,844,260) 812,244 3,462,754 3,005,466
Commitments and contingencies (Note 18)    
STOCKHOLDERS' DEFICIT                
Additional paid-in capital         0      
Accumulated deficit     3,902,384 2,322,725 1,844,260 (812,244) (3,462,754) (3,005,466)
Total liabilities and stockholders' deficit     0   0      
Investment In Unconsolidated Entities Adjustment [Member]                
ASSETS                
Investment in unconsolidated entities         (503,100)      
Option to purchase equity securities in related parties         960,968      
Property and equipment, net         0      
Total assets         457,868      
LIABILITIES AND STOCKHOLDERS' DEFICIT                
Accounts payable         0      
Accrued expenses         0      
Loans payable         0      
Litigation financing and other         0      
Deferred revenue         960,968      
Warrant liability         0      
Total liabilities         960,968      
Commitments and contingencies (Note 18)              
STOCKHOLDERS' DEFICIT                
Additional paid-in capital         0      
Accumulated deficit         (503,100)      
Total liabilities and stockholders' deficit         457,868      
2022 Warrant Adjustment [Member]                
ASSETS                
Investment in unconsolidated entities         0      
Option to purchase equity securities in related parties         0      
Property and equipment, net         0      
Total assets         0      
LIABILITIES AND STOCKHOLDERS' DEFICIT                
Accounts payable         0      
Accrued expenses         0      
Loans payable         0      
Deferred revenue         0      
Warrant liability         13,602,467      
Total liabilities         13,602,467      
Commitments and contingencies (Note 18)              
STOCKHOLDERS' DEFICIT                
Additional paid-in capital         (8,919,015)      
Accumulated deficit         (4,683,452)      
Total liabilities and stockholders' deficit         0      
Other Adjustments [Member]                
ASSETS                
Investment in unconsolidated entities         0      
Option to purchase equity securities in related parties         0      
Property and equipment, net     922,121 634,256 131,123      
Total assets     911,794 627,408 131,123      
LIABILITIES AND STOCKHOLDERS' DEFICIT                
Accounts payable         2      
Accrued expenses         (2)      
Loans payable       931,425 0      
Litigation financing and other         0      
Deferred revenue         0      
Warrant liability         0      
Total liabilities     (4,918)   0     311,123
Commitments and contingencies (Note 18)    
STOCKHOLDERS' DEFICIT                
Additional paid-in capital     (232,175) (232,175) 0 (232,175) (232,175) (232,175)
Accumulated deficit     1,148,887 859,583 131,123 $ 232,175 $ 232,175 $ (78,948)
Total liabilities and stockholders' deficit     $ 911,794 $ 627,408 $ 131,123